NovaBay Pharmaceuticals Inc Strategic Asset Allocation Index
NovaBay Pharmaceuticals Inc strategic asset allocation index. NovaBay Pharmaceuticals Inc (NBY) has a Strategic Asset Allocation Index of 11.9% as of September 2025. Strategic assets (PP&E of $195.00K plus long-term investments of $-) total $195.00K, measured against net assets of $1.63 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See NovaBay Pharmaceuticals Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of NovaBay Pharmaceuticals Inc (2005–2023)
Strategic asset allocation index of NovaBay Pharmaceuticals Inc from 2005 to 2023. This chart shows how NovaBay Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 18 annual periods from 2005 to 2023. As of September 2025, the index stands at 11.9%, representing strategic assets of $195.00K against net assets of $1.63 Million USD. Check NovaBay Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
NovaBay Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2005–2023)
NovaBay Pharmaceuticals Inc strategic asset allocation index by year from 2005 to 2023. The table below presents the year-by-year Strategic Asset Allocation Index for NovaBay Pharmaceuticals Inc from 2005 to 2023, covering 18 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of NovaBay Pharmaceuticals Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 41.7% | $1.38 Million | $1.38 Million | $- | $3.31 Million | ▲ +23.3 pp |
| 2022 | 18.5% | $1.95 Million | $1.95 Million | $- | $10.55 Million | ▲ +12.5 pp |
| 2021 | 5.9% | $604.00K | $604.00K | $- | $10.17 Million | ▲ +1.7 pp |
| 2020 | 4.2% | $520.00K | $520.00K | $- | $12.32 Million | ▼ -7.1 pp |
| 2019 | 11.3% | $110.00K | $110.00K | $- | $973.00K | ▲ +7.2 pp |
| 2018 | 4.1% | $201.00K | $201.00K | $- | $4.95 Million | ▼ -14.1 pp |
| 2017 | 18.2% | $471.00K | $471.00K | $- | $2.59 Million | ▲ +12.9 pp |
| 2016 | 5.2% | $371.00K | $371.00K | $- | $7.10 Million | ▼ -18.4 pp |
| 2014 | 23.6% | $436.00K | $436.00K | $- | $1.85 Million | ▲ +15.2 pp |
| 2013 | 8.4% | $718.00K | $718.00K | $- | $8.52 Million | ▲ +2.1 pp |
| 2012 | 6.3% | $891.00K | $891.00K | $- | $14.05 Million | ▼ -7.2 pp |
| 2011 | 13.6% | $1.27 Million | $1.27 Million | $- | $9.34 Million | ▼ -1.5 pp |
| 2010 | 15.1% | $1.59 Million | $1.59 Million | $- | $10.49 Million | ▲ +1.6 pp |
| 2009 | 13.6% | $1.81 Million | $1.81 Million | $- | $13.35 Million | ▼ -6.2 pp |
| 2008 | 19.8% | $1.46 Million | $1.46 Million | $- | $7.34 Million | ▲ +11.8 pp |
| 2007 | 8.0% | $1.15 Million | $1.15 Million | $- | $14.32 Million | ▼ -22.5 pp |
| 2006 | 30.6% | $554.00K | $554.00K | $- | $1.81 Million | ▲ +22.3 pp |
| 2005 | 8.2% | $267.00K | $267.00K | $- | $3.25 Million | — |